Asthma is associated with a lower incidence of metastatic colorectal cancer in a US patient cohort.

adenocarcinoma asthma cancer colorectal electronic medical record metastasis

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2023
Historique:
received: 05 07 2023
accepted: 13 09 2023
medline: 20 10 2023
pubmed: 20 10 2023
entrez: 20 10 2023
Statut: epublish

Résumé

In previous pre-clinical studies, we examined the contribution of interleukin 4 receptor (IL4R) signaling in the progression and metastasis of colorectal cancer (CRC). Aberrant activation of this receptor can result in atopic diseases such as asthma. We hypothesized that further evidence for the contribution of excessive IL4R being associated with CRC progression could be seen in medical records, and specifically that chronic asthma patients were more likely to be diagnosed with metastatic CRC. To test this hypothesis, we took advantage of the Synthetic Derivative, a resource developed at Vanderbilt University Medical Center that hosts de-identified data taken from the electronic medical record. We developed search protocols that produced retrospective cohorts of invasive CRC patients and cancer-free equivalents. In comparing 787 metastatic CRC patients to 238 non-metastatic patients, we actually found significantly fewer asthmatics went on to develop metastatic CRC (P=0.0381). By comparing these groups together against 1197 cancer-free patients, even fewer asthmatic patients would develop invasive CRC (P<0.0001). While these results are clearly in opposition to our original hypothesis, they still support a link between chronic asthma and metastatic CRC development. One intriguing possibility, that will be examined in the future, is whether treatment for chronic asthma may be responsible for the reduction in metastatic cancer.

Identifiants

pubmed: 37860183
doi: 10.3389/fonc.2023.1253660
pmc: PMC10584144
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1253660

Informations de copyright

Copyright © 2023 Beckstead, Mehrotra, Wilson and Fingleton.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Tissue Antigens. 2006 Jul;68(1):1-12
pubmed: 16774534
Egypt J Immunol. 2018 Jan;25(1):19-33
pubmed: 30242995
Cell Mol Gastroenterol Hepatol. 2021;11(5):1505-1518
pubmed: 33316454
Eur Respir J. 2019 Jun 5;53(6):
pubmed: 30956205
Cancer Med. 2023 May;12(10):11871-11877
pubmed: 36999938
Nat Genet. 1998 Jun;19(2):119-20
pubmed: 9620765
Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1395-1403
pubmed: 31167755
Ann Transl Med. 2019 Nov;7(21):609
pubmed: 32047770
Neoplasia. 2022 Oct;32:100830
pubmed: 35939881
Sci Rep. 2021 Feb 25;11(1):4539
pubmed: 33633205
Carcinogenesis. 2010 Jun;31(6):1010-7
pubmed: 20176658
Pediatr Blood Cancer. 2022 Mar;69(3):e29402
pubmed: 34662484
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):661-9
pubmed: 23513040
Science. 2017 Jul 07;357(6346):55-60
pubmed: 28684519
Eur J Clin Invest. 2021 Feb;51(2):e13434
pubmed: 33053199
Ann Allergy Asthma Immunol. 2018 Nov;121(5):613-618
pubmed: 30086407
Clin Exp Metastasis. 2015 Dec;32(8):847-56
pubmed: 26385103
Int J Cancer. 2018 Nov 1;143(9):2311-2318
pubmed: 29943812
Science. 2006 Sep 29;313(5795):1960-4
pubmed: 17008531
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013 Jun;157(2):172-80
pubmed: 23752766
Carcinogenesis. 2013 Oct;34(10):2341-9
pubmed: 23784081
Curr Opin Genet Dev. 2009 Jun;19(3):279-82
pubmed: 19481925
J Allergy Clin Immunol. 2000 Jul;106(1 Pt 1):135-40
pubmed: 10887316
Ann Thorac Med. 2018 Jul-Sep;13(3):156-162
pubmed: 30123334
Curr Issues Mol Biol. 2023 Apr 01;45(4):2895-2907
pubmed: 37185713
PLoS One. 2021 May 13;16(5):e0250430
pubmed: 33983952
Front Immunol. 2020 May 28;11:1052
pubmed: 32547556
Sci Rep. 2019 Aug 2;9(1):11257
pubmed: 31375708
J Exp Med. 2009 Sep 28;206(10):2191-204
pubmed: 19770271
J Immunother Cancer. 2022 Oct;10(10):
pubmed: 36220303
N Engl J Med. 1997 Dec 11;337(24):1720-5
pubmed: 9392697
Clin Transl Oncol. 2011 Oct;13(10):728-30
pubmed: 21975334
Nat Genet. 2019 Jul;51(7):1113-1122
pubmed: 31209394
Cancer Res. 2014 Aug 15;74(16):4329-40
pubmed: 24947041
Genet Mol Res. 2015 Mar 31;14(1):2900-11
pubmed: 25867440
Afr Health Sci. 2022 Sep;22(3):307-316
pubmed: 36910341
Clin Pharmacol Ther. 2008 Sep;84(3):362-9
pubmed: 18500243
Cancers (Basel). 2021 Sep 04;13(17):
pubmed: 34503270
CA Cancer J Clin. 2023 May-Jun;73(3):233-254
pubmed: 36856579
Ann Oncol. 2015 Aug;26(8):1784-90
pubmed: 25969367
Clin Chem Lab Med. 2003 Jul;41(7):888-92
pubmed: 12940513
Colorectal Dis. 2010 Dec;12(12):1208-12
pubmed: 19863607
J Allergy Clin Immunol. 2021 Jan;147(1):135-143
pubmed: 32417133
JCI Insight. 2021 Dec 22;6(24):
pubmed: 34784298
Rheum Dis Clin North Am. 2016 Feb;42(1):15-31, vii
pubmed: 26611548
Biomedicines. 2020 Oct 13;8(10):
pubmed: 33066148

Auteurs

Jacob Beckstead (J)

Program in Cancer Biology, Department of Pharmacology, Vanderbilt University, Nashville, TN, United States.

Kunaal Mehrotra (K)

Program in Cancer Biology, Department of Pharmacology, Vanderbilt University, Nashville, TN, United States.

Kayla Wilson (K)

Program in Cancer Biology, Department of Pharmacology, Vanderbilt University, Nashville, TN, United States.

Barbara Fingleton (B)

Program in Cancer Biology, Department of Pharmacology, Vanderbilt University, Nashville, TN, United States.

Classifications MeSH